Research Topics
| Kenneth PetersSummaryAffiliation: William Beaumont Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP StudyKenneth M Peters
Beaumont Health System, Royal Oak, Michigan Electronic address
J Urol 189:2194-201. 2013..We report the long-term efficacy and safety of percutaneous tibial nerve stimulation with the Urgent® PC Neuromodulation System for overactive bladder after 3 years of therapy...- Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP studyKenneth M Peters
Department of Urology Beaumont Health System, Royal Oak, MI 48073, USA
Neurourol Urodyn 32:24-9. 2013..To evaluate the safety, sustained effectiveness, and treatment interval for percutaneous tibial nerve stimulation (PTNS) for overactive bladder (OAB) therapy through 24 months... 
Frequency, urgency, and pelvic pain: treating the pelvic floor versus the epitheliumKenneth M Peters
3535 West 13 Mile Road, Suite 438, Royal Oak, MI 48073, USA
Curr Urol Rep 7:450-5. 2006..Pelvic floor therapies should be a first line of treatment for those women with chronic pelvic pain related to pelvic floor dysfunction...- A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitisKenneth M Peters
Department of Urology, Ministrelli Program for Urologic Research and Education MPURE, William Beaumont Hospital, Royal Oak, Michigan, USA
BJU Int 100:835-9. 2007..To compare sacral nerve stimulation (SNS) with pudendal nerve stimulation (PNS) for interstitial cystitis (IC)... - Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trialKenneth M Peters
Department of Urology, Ministrelli Program for Urologic Research and Education MPURE, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Neurourol Urodyn 24:643-7. 2005..The objective of the study was to compare sacral nerve stimulation (SNS) to pudendal nerve stimulation (PNS) for voiding dysfunction... - Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trialKenneth M Peters
Department of Urology, Beaumont Hospital, Royal Oak, Michigan 48073, USA
J Urol 183:1438-43. 2010..The improvement in global response assessment, voiding diary parameters, and overactive bladder and quality of life questionnaires was evaluated... - Alternative approaches to sacral nerve stimulationKenneth M Peters
Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
Int Urogynecol J 21:1559-63. 2010..A benefit of neuromodulation is that it is minimally invasive and reversible. New sites of stimulation are being developed to add to our treatment options... - Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trialKenneth M Peters
William Beaumont Hospital, Royal Oak, Michigan, USA
J Urol 182:1055-61. 2009..The reduction in overactive bladder symptoms along with global response assessments was evaluated... - Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitisK M Peters
Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 438, Royal Oak, Michigan, USA
BJU Int 93:777-9. 2004..Minneapolis, MN) in treating chronic pelvic pain associated with interstitial cystitis (IC, a symptom complex of urinary urgency, frequency and pelvic pain, often necessitating narcotics) refractory to standard therapy... - Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on techniqueKenneth M Peters
Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Rd, Suite 438, Royal Oak, MI 48073, USA
Int Urogynecol J Pelvic Floor Dysfunct 14:223-8; discussion 228. 2003..We concluded that sacral nerve modulation can treat refractory IC symptoms. The response to therapy and the reoperation rate are dependent on the technique used to test and implant the device... - Fact or fiction--is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic populationKenneth M Peters
Department of Urology, Ministrelli Program for Urologic Research and Education, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
J Urol 178:891-5; discussion 895. 2007..We determined whether abuse is associated with interstitial cystitis by surveying patients with interstitial cystitis and controls. We corroborated this association in a clinic population... - Sexual function and sexual distress in women with interstitial cystitis: a case-control studyKenneth M Peters
Ministrelli Program for Urologic Research and Education, Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Urology 70:543-7. 2007..To evaluate female sexual dysfunction (FSD) in women with interstitial cystitis (IC) versus a control group. Specific areas of FSD in women with IC have not been reported... - Validation of a sham for percutaneous tibial nerve stimulation (PTNS)Kenneth Peters
Beaumont Hospital, Department of Urology, Royal Oak, Michigan 48073, USA
Neurourol Urodyn 28:58-61. 2009..Percutaneous tibial nerve stimulation (PTNS) supposedly demonstrates 50-60% improvement in OAB symptoms with no sham-controlled trials reported. This study determined the efficacy of a sham for PTNS... - Prevalence of self-reported interstitial cystitis (IC) and interstitial-cystitis-like symptoms among adult women in the communityIbrahim A Ibrahim
William Beaumont Hospital, Royal Oak, MI, USA
Int Urol Nephrol 39:489-95. 2007..Reported estimates of IC prevalence vary widely. The objective of this study is to determine the prevalence of IC among community-dwelling adult women... - Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot studyDonna J Carrico
William Beaumont Hospital, Department of Urology, Royal Oak, MI 48073, USA
J Altern Complement Med 14:53-60. 2008..The purpose of this clinical investigation was to explore the effect of guided imagery on pelvic pain and urinary symptoms in women with IC symptoms... - The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequencyKenneth M Peters
Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Neurourol Urodyn 27:775-8. 2008.... - Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitisMichael S Ingber
Department of Urology, Ministrelli Program for Urologic Research and Education, William Beaumont Hospital, Royal Oak, MI, USA
Int Urogynecol J Pelvic Floor Dysfunct 19:341-5. 2008..Women with IC have significantly more pelvic surgeries than controls. The majority of these surgeries were done before the diagnosis of IC and may be performed for pain related to undiagnosed IC... - Comparison of patients undergoing a two-stage sacral nerve stimulation procedure: is there a cost benefit for a single-stage procedure?Dmitriy Nikolavsky
Ministrelli Program for Urology Research and Education, Beaumont Hospital, Royal Oak, MI, USA
Int Urol Nephrol 43:997-1002. 2011..This study's purpose was to determine the overall response rate, costs of a two-staged versus single-stage approach, and explore predictors of a positive response... - Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndromeKenneth M Peters
Ministrelli Program for Urology Research and Education, Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Urology 71:634-40. 2008..This was reported with the National Institutes of Health chronic prostatitis cohort, but a literature review did not reveal a similar study for women with IC/PBS... - Sacral neuromodulation reprogramming: is it an office burden?Frank N Burks
Department of Urology, William Beaumont Hospital, 3535 W 13 Mile Road Suite 438, Royal Oak, MI 48073, USA
Int Urogynecol J Pelvic Floor Dysfunct 19:1137-40. 2008..These data suggest that the number of reprogramming episodes is small, and the majority is done as part of routine follow-up. No additional burden was seen in subjects with interstitial cystitis... - Prevalence of pelvic floor dysfunction in patients with interstitial cystitisKenneth M Peters
Ministrelli Program for Urology Research and Education, Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Urology 70:16-8. 2007..To evaluate the prevalence of pelvic floor dysfunction in women with interstitial cystitis (IC)... - Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlationKenneth Peters
Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA
Int Urogynecol J Pelvic Floor Dysfunct 19:665-9. 2008..The correlation of vulvodynia and PBS/IC may have been underestimated. Research needs to explore the link between precipitating factors, symptoms, and effective treatment options for PBS/IC and vulvodynia... - Childhood symptoms and events in women with interstitial cystitis/painful bladder syndromeKenneth M Peters
Department of Urology, Ministrelli Program for Urology Research and Education, William Beaumont Hospital, Royal Oak, Michigan 48073, USA
Urology 73:258-62. 2009..The relationship between dysfunctional voiding and bowel symptoms in early life and the development of IC/PBS is not clear... - Neuromodulation versus medication for overactive bladder: the case for early interventionFrank N Burks
William Beaumont Hospital, 3535 West Thirteen Mile Road, Suite 438, Royal Oak, MI 48073, USA
Curr Urol Rep 10:342-6. 2009..Neuromodulation is a well-established treatment for "refractory" OAB that deserves a place among traditional treatments for OAB... - The relationship of interstitial cystitis/painful bladder syndrome to vulvodyniaDonna J Carrico
The WISH Program, Department of Urology Beaumont Hospital, Royal Oak, MI, USA
Urol Nurs 29:233-8. 2009..The vulva, not the urethra or bladder, may actually be the site of some of the reported pain in women with IC/PBS... - Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladderRoger R Dmochowski
Department of Urology, Vanderbilt University Medical Center, Room A 1302, Medical Center North, Nashville, TN 37232, USA
Urology 75:62-8. 2010..To evaluate the efficacy and tolerability of flexible-dose fesoterodine vs placebo in subjects with overactive bladder (OAB)... - Neuromodulation and the neurogenic bladderFrank N Burks
Department of Urology, William Beaumont Hospital, 3535 West Thirteen Mile Road, Suite 438 MOB, Royal Oak, MI 48073, USA
Urol Clin North Am 37:559-65. 2010..Neuromodulation, both electrical and physical, play an important role in the management of neurogenic bladder... - Expanding indications for neuromodulationAndrew J Bernstein
Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 438, Royal Oak, MI 48073, USA
Urol Clin North Am 32:59-63. 2005..Rather, by modulating the nerves, the urologists will treat these disorders in a minimally invasive fashion and neuromodulation will become the first-line therapy before any major surgery is undertaken... - Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit?Michael S Ingber
Department of Urology, Ministrelli Program for Urology Research and Education MPURE, William Beaumont Hospital, 3535 W Thirteen Mile Rd Suite 438, Royal Oak, MI 48073, USA
Int Urogynecol J Pelvic Floor Dysfunct 20:1055-9. 2009..Women undergoing InterStim implantation for overactive bladder (OAB) or painful bladder syndrome (PBS) were prospectively evaluated to determine if neuromodulation has any effect on female sexual function (FSF)... - Outcomes of lumbar to sacral nerve rerouting for spina bifidaKenneth M Peters
Department of Urology, William Beaumont Hospital, Royal Oak, Michigan, USA
J Urol 184:702-7. 2010..We report 1-year results of the first North American trial on nerve rerouting... - A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitisWilliam D Tissot
Department of Urology, William Beaumont Hospital, Royal Oak, Michigan, USA
J Urol 172:478-80. 2004..One would expect that this number would increase if the criteria to diagnose IC and initiate treatment were oversimplified. Interstitial cystitis remains a diagnosis of exclusion... - Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitisJ Curtis Nickel
Department of Urology, Queen s University, Kingston General Hospital, Kingston, Ontario, Canada
J Urol 177:1832-6. 2007..Interstitial cystitis significantly negatively impacts quality of life. The demographic and clinical factors associated with decreased quality of life in these patients have not been well studied... - Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled studyScott A MacDiarmid
Alliance Urology Specialists, Greensboro, NC 27403, USA
Mayo Clin Proc 83:1002-10. 2008..To evaluate the efficacy and tolerability of extended-release oxybutynin in combination with the alpha1-blocker tamsulosin in reducing lower urinary tract symptoms in men... - Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?Kathleen Joy Propert
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Blockley Hall, 6th Floor, 423 Guardian Dr, Philadelphia, Pennsylvania 19104, USA
J Urol 178:886-90. 2007.... - Is urine methylhistamine a useful marker for interstitial cystitis?Deborah R Erickson
Department of Surgery Division of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA
J Urol 172:2256-60. 2004..We determined whether urine methylhistamine (MH) is associated with other clinical features and bladder biopsy findings in interstitial cystitis (IC)... 
Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndromeDeborah R Erickson
Department of Surgery, Division of Urology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0298, USA
J Urol 179:1850-6. 2008..We tested for associations between urine markers, bladder biopsy features and bladder ulcers in interstitial cystitis/painful bladder syndrome...- Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?Deborah R Erickson
From the Department of Surgery, Division of Urology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
J Urol 173:93-7. 2005.... - A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitisRobert Mayer
University of Rochester, Rochester, New York, USA
J Urol 173:1186-91. 2005..CONCLUSIONS: Although the BCG safety profile was acceptable, the response rate for the primary outcome was low. Effective medical treatment for patients with moderate to severe interstitial cystitis remains elusive... - Changes in urine markers and symptoms after bladder distention for interstitial cystitisDeborah R Erickson
Department of Surgery, Division of Urology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0298, USA
J Urol 177:556-60. 2007..We evaluated changes in urine markers and symptom scores after bladder distention in patients with interstitial cystitis... - Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placeboKathleen Joy Propert
University of Pennsylvania, Philadelphia, Pennsylvania, USA
J Urol 179:552-5. 2008..We evaluated the longer term response in patients with interstitial cystitis who initially responded to intravesical bacillus Calmette-Guerin or placebo in a randomized clinical trial... - Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitisChen-O u Zhang
Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
Urology 61:897-901. 2003..000001, respectively), than their matched asymptomatic controls. CONCLUSIONS: These findings confirm the utility of APF, HB-EGF, and EGF as biomarkers for IC in patients from three different racial groups and two different countries... - Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladderRobert B Armstrong
Clinical Affairs, Ortho McNeil Pharma ceutical, Inc, Raritan, NJ 08869, USA
Int Urol Nephrol 37:247-52. 2005..380). The results of this analysis showed that dry mouth was common with both treatments, but most events were mild; there was no difference in the rate of severe dry mouth or in the rate of withdrawal due to dry mouth...
Research Grants
- Safety and Efficacy of Nerve Rerouting for Treating Neurogenic Bladder in Spina BKenneth M Peters; Fiscal Year: 2010..Dr. Xiao, in China, developed a new procedure to rewire the nerves affecting the bladder, and this project aims to scientifically establish the safety and effectiveness of the surgical procedure. ..
- Beaumont Interstitial Cystitis Clinical Research NetworkKenneth Peters; Fiscal Year: 2007..Adverse events and complications will be monitored. Ancillary studies as agreed upon by the ICCRN will be carried out in conjunction with the clinical trial. ..